Related Experiment Videos

Methods for homocysteine analysis and biological relevance of the results

Véronique Ducros1, Karine Demuth, Marie-Pierre Sauvant

  • 1Département de Biologie Intégrée, CHU Grenoble, BP 217, 38043 Grenoble, France. vducros@chu-grenoble.fr

Insights

Elevated total plasma homocysteine (tHcy) is a cardiovascular disease risk factor, often due to genetic or vitamin B deficiencies. This review analyzes homocysteine testing methods, highlighting transferability issues impacting results.

Area of Science:

  • Clinical Chemistry
  • Cardiovascular Disease Research
  • Biochemical Analysis

Background:

  • Increased total plasma homocysteine (tHcy) is a recognized risk factor for cardiovascular disease.
  • Hyperhomocysteinemia stems from genetic mutations or deficiencies in B vitamins (B2, B6, B9, B12), impairing enzyme function.

Purpose of the Study:

  • To review and compare the characteristics, performance, and limitations of current analytical methods for determining tHcy.
  • To aid researchers and clinicians in selecting an appropriate homocysteine assay.

Main Methods:

  • Review of High-Pressure Liquid Chromatography (HPLC) with fluorescence detection.
  • Evaluation of immunoassays as increasingly popular alternatives to in-house laboratory methods.

Main Results:

  • HPLC with fluorescence detection is widely used, while immunoassays offer ease of use and are gaining traction.
  • A significant drawback across methods is the lack of clearly established transferability between different assays and laboratories.

Conclusions:

  • Method selection for tHcy determination requires careful consideration of performance, ease of use, and especially method transferability.
  • Inter-method and inter-laboratory variations pose challenges for consistent interpretation of tHcy results, necessitating standardization efforts.

Related Concept Videos